Scarica l'app Stockscreener
1.50
1.96%
-0.03
Dopo l'orario di chiusura:
1.50
Precedente Chiudi:
$1.53
Aprire:
$1.555
Volume 24 ore:
43,477
Relative Volume:
0.89
Capitalizzazione di mercato:
$8.74M
Reddito:
-
Utile/perdita netta:
$-14.29M
Rapporto P/E:
-0.3759
EPS:
-3.99
Flusso di cassa netto:
$-12.27M
1 W Prestazione:
-5.36%
1M Prestazione:
-11.76%
6M Prestazione:
-41.18%
1 anno Prestazione:
-57.14%
Intervallo 1D:
$1.49
$1.555
Intervallo di 1 settimana:
$1.49
$1.65
Portata 52W:
$1.412
$5.01
Aprea Therapeutics Inc Stock (APRE) Company Profile
Nome
Aprea Therapeutics Inc
Settore
Industria
Telefono
215-948-4119
Indirizzo
3805 OLD EASTON ROAD, DOYLESTOWN, MA
Confronta APRE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
APRE
Aprea Therapeutics Inc
|
1.50 | 9.15M | 0 | -14.29M | -12.27M | -3.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-12-28 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | Iniziato | Berenberg | Buy |
| 2020-09-29 | Ripresa | JP Morgan | Neutral |
| 2020-06-22 | Iniziato | H.C. Wainwright | Neutral |
| 2020-04-21 | Iniziato | Robert W. Baird | Outperform |
| 2019-10-28 | Iniziato | JP Morgan | Neutral |
| 2019-10-28 | Iniziato | Morgan Stanley | Equal-Weight |
| 2019-10-28 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Aprea Therapeutics Inc Borsa (APRE) Ultime notizie
How to use a screener to detect Aprea Therapeutics Inc. breakoutsBear Alert & Safe Capital Growth Stock Tips - Newser
What institutional flow reveals about Aprea Therapeutics Inc.2025 Technical Patterns & High Accuracy Swing Entry Alerts - Newser
How moving averages guide Aprea Therapeutics Inc. trading2025 Volatility Report & Growth Focused Entry Point Reports - Newser
Can a trend reversal in Aprea Therapeutics Inc. lead to recoveryJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - Newser
Can technical indicators confirm Aprea Therapeutics Inc.’s reversalTrade Analysis Report & Risk Managed Trade Strategies - Newser
Identifying reversal signals in Aprea Therapeutics Inc.Market Activity Report & Growth Oriented Trade Recommendations - Newser
Price action breakdown for Aprea Therapeutics Inc.Quarterly Growth Report & Weekly High Return Opportunities - Newser
Chart based exit strategy for Aprea Therapeutics Inc.Earnings Recap Summary & Growth Focused Stock Reports - Newser
Should you hold or exit Aprea Therapeutics Inc. nowMarket Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser
Aprea Therapeutics Inc. recovery potential after sell offJuly 2025 PostEarnings & Real-Time Volume Analysis - Newser
Aprea Therapeutics Inc. stock retracement – recovery analysis2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Is Aprea Therapeutics Inc. stock influenced by commodity prices2025 Momentum Check & Capital Protection Trade Alerts - khodrobank.com
What drives Aprea Therapeutics Inc.’s stock price2025 Fundamental Recap & Stock Portfolio Risk Management - khodrobank.com
Using Ichimoku Cloud for Aprea Therapeutics Inc. technicalsWeekly Stock Summary & Expert Verified Movement Alerts - Newser
Aprea Therapeutics Inc.’s volatility index tracking explainedPortfolio Performance Summary & Low Risk Entry Point Guides - Newser
What is Aprea Therapeutics Inc.’s market positionQuarterly Performance Summary & Community Consensus Stock Picks - خودرو بانک
Using RSI to spot recovery in Aprea Therapeutics Inc.2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Is Aprea Therapeutics Inc. forming a bullish divergenceQuarterly Profit Report & Weekly Setup with High ROI Potential - خودرو بانک
Will Aprea Therapeutics Inc. benefit from geopolitical trendsQuarterly Profit Report & Real-Time Volume Spike Alerts - khodrobank.com
Trend analysis for Aprea Therapeutics Inc. this weekMarket Risk Analysis & Weekly High Return Opportunities - Newser
Visual analytics tools that track Aprea Therapeutics Inc. performanceJuly 2025 Big Picture & Expert Curated Trade Setup Alerts - Newser
What’s next for Aprea Therapeutics Inc. stock priceEntry Point & Free AI Powered Buy and Sell Recommendations - Newser
What is Aprea Therapeutics Inc.’s valuation compared to sectorMarket Sentiment Summary & Stepwise Trade Signal Implementation - khodrobank.com
Is Aprea Therapeutics Inc. stock a good pick for beginnersTrade Entry Report & Fast Entry Momentum Alerts - khodrobank.com
Analyzing Aprea Therapeutics Inc. with multi timeframe chartsJuly 2025 Selloffs & Verified High Yield Trade Plans - Newser
Aprea Therapeutics Inc. stock daily chart insightsMarket Movers & AI Enhanced Execution Alerts - Newser
Using R and stats models for Aprea Therapeutics Inc. forecasting2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
Comparing Aprea Therapeutics Inc. in custom built stock radars2025 Momentum Check & High Accuracy Swing Trade Signals - Newser
Real time breakdown of Aprea Therapeutics Inc. stock performanceMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - Newser
Market reaction to Aprea Therapeutics Inc.’s recent newsQuarterly Profit Review & Low Risk Entry Point Guides - Newser
Volatility clustering patterns for Aprea Therapeutics Inc.2025 Market Outlook & Long Hold Capital Preservation Tips - Newser
Multi factor analysis applied to Aprea Therapeutics Inc.2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
Backtesting results for Aprea Therapeutics Inc. trading strategiesMarket Trend Summary & Reliable Intraday Trade Plans - Newser
Pattern recognition hints at Aprea Therapeutics Inc. upsideTrade Analysis Summary & Safe Capital Growth Trade Ideas - Newser
Sentiment Tools Show Shift in Trader Mood on Aprea Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Aprea Therapeutics Inc Azioni (APRE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aprea Therapeutics Inc Azioni (APRE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Duey Marc | Director |
Oct 18 '24 |
Sale |
4.58 |
6,462 |
29,583 |
233,651 |
| Gilad Oren | President/CEO |
Oct 23 '24 |
Buy |
3.92 |
500 |
1,958 |
333,395 |
| Duey Marc | Director |
Oct 16 '24 |
Buy |
4.39 |
30,000 |
131,700 |
240,113 |
| Gilad Oren | President/CEO |
Oct 15 '24 |
Buy |
2.90 |
250 |
725 |
332,895 |
| Duey Marc | Director |
Oct 14 '24 |
Buy |
2.58 |
190 |
490 |
210,113 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr |
Oct 11 '24 |
Buy |
2.46 |
50 |
123 |
19,368 |
| Seizinger Bernd R. | Director |
Oct 11 '24 |
Buy |
2.68 |
10,000 |
26,800 |
44,730 |
| Gilad Oren | President/CEO |
Oct 14 '24 |
Buy |
2.59 |
1,000 |
2,590 |
332,645 |
| Gilad Oren | President/CEO |
Oct 10 '24 |
Buy |
2.54 |
150 |
381 |
331,645 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr |
Oct 10 '24 |
Buy |
2.61 |
450 |
1,174 |
19,318 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):